Class III receptor tyrosine kinases: role in leukaemogenesis. - sprookjes - yvandenbroek - TriplyDB

Class III receptor tyrosine kinases: role in leukaemogenesis.

Class III receptor tyrosine kinases: role in leukaemogenesis.

http://www.wikidata.org/entity/Q34557003

about

Protein tyrosine phosphatase 1B negatively regulates macrophage development through CSF-1 signaling.Discovery of a novel mode of protein kinase inhibition characterized by the mechanism of inhibition of human mesenchymal-epithelial transition factor (c-Met) protein autophosphorylation by ARQ 197 Therapy-related acute myeloid leukemia with eosinophilia, basophilia, t(4;14)(q12;q24) and PDGFRA rearrangement: a case report and review of the literature Molecular Dynamics Studies on D835N Mutation in FLT3-Its Impact on FLT3 Protein Structure.AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec.Mutational analysis of class III receptor tyrosine kinases (C-KIT, C-FMS, FLT3) in idiopathic myelofibrosis.Expression profiling of CD34+ hematopoietic stem/ progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia.Prevalence of c-KIT mutations in gonadoblastoma and dysgerminomas of patients with disorders of sex development (DSD) and ovarian dysgerminomas.Small molecule tyrosine kinase inhibitors: clinical development of anticancer agents.Screening of C-kit gene Mutation in Acute Myeloid Leukaemia in Northern India FLT3: ITDoes matter in leukemia.Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers.Novel FLT3 tyrosine kinase inhibitors.Neoplasia driven by mutant c-KIT is mediated by intracellular, not plasma membrane, receptor signaling.Human leukaemic stem cells: a novel target of therapy.Molecular classification and pathogenesis of eosinophilic disorders: 2005 update.Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation.Fusion of platelet-derived growth factor receptor β to CEV14 gene in chronic myelomonocytic leukemia: A case report and review of the literature.Cytogenetic and FMS-like tyrosine kinase 3 mutation analyses in acute promyelocytic leukemia patients.Hidden abnormalities and novel classification of t(15;17) acute promyelocytic leukemia (APL) based on genomic alterations The novel HSP90 inhibitor STA-9090 exhibits activity against Kit-dependent and -independent malignant mast cell tumors The Frequency of Mutations in Exon 11 of the c-kit Gene in Patients With Leukemia.Gene of the month: KIT.Discovery of imatinib-responsive FIP1L1-PDGFRA mutation during refractory acute myeloid leukemia transformation of chronic myelomonocytic leukemia.The fusion proteins TEL-PDGFRbeta and FIP1L1-PDGFRalpha escape ubiquitination and degradation Roles of tyrosine residues 845, 892 and 922 in constitutive activation of murine FLT3 kinase domain mutant.FLT3 mutations in acute myeloid leukemia cell lines.A potentially functional polymorphism in ABCG2 predicts clinical outcome of non-small cell lung cancer in a Chinese population.Switching on kinases: oncogenic activation of BRAF and the PDGFR family.Tandutinib inhibits FMS receptor signalling, and macrophage and osteoclast formation in vitro.Cooperating mutations of receptor tyrosine kinases and Ras genes in childhood core-binding factor acute myeloid leukemia and a comparative analysis on paired diagnosis and relapse samples.Dihydroartemisinin selectively inhibits PDGFRα-positive ovarian cancer growth and metastasis through inducing degradation of PDGFRα protein.Prevalence of FMS-like tyrosine kinase 3/internal tandem duplication (FLT3/ITD+) in de novo acute myeloid leukemia patients categorized according to cytogenetic risk.KIT proto-oncogene exon 8 deletions at codon 419 are highly frequent in acute myeloid leukaemia with inv(16) in Indian population.Screening of the c-kit gene missense mutation in invasive ductal carcinoma of breast among north Indian population.Expression of c-kit protein and mutational status of the c-kit gene in osteosarcoma and their clinicopathological significance.Acute myeloid leukemia with t(4;12)(q12;p13): an aggressive disease with frequent involvement of PDGFRA and ETV6.

P2860

Q24541468-0C768CDA-666E-4A27-96B3-C3C21EA951CF Q24608143-417E59B1-BBC8-4170-909A-A8BBF6AD3F10 Q26801945-BF4373D4-E1E6-4F44-8BB7-7F49CC97C90B Q30381343-608F2389-4E88-44AE-BAA0-05653825486D Q33762738-DD974CF8-17A7-40A0-8786-8F75BE5D044B Q34176633-DE2C2495-C6DA-4C22-86E4-432DE52CF9DC Q34380411-9669B7E7-07B7-443B-B48F-44AC958CD5C0 Q34399597-84E7DCD5-74D7-4E7B-961A-FB33298509E9 Q35040797-360918E8-00C6-4D4E-8D1B-723B3A6C00BA Q35156200-F1A1E168-2C8B-4EE1-A99E-1351C409E707 Q35217399-61006E62-1C81-491D-A4A2-00C534CCE508 Q35459525-5FCC78CD-660B-4C18-A6D3-D1E890AF8EE7 Q35594041-C7B481FC-E390-4DEE-A5B0-9D62CA401ABE Q35641644-DBA66954-F7CA-4A93-9B07-B53B0BC2DDA4 Q35854964-09C1D329-101E-444B-8F2E-3EC39EE10E63 Q36182741-8D8A68E7-901B-43BD-9D46-A768BA850CAA Q36403080-2F70F499-53F2-4237-AEAA-FDF9D53E904A Q36502974-3C91CF6B-768D-4B2F-8443-C0F0D631F792 Q36734284-2009FA74-D757-4BFF-AAEA-7E409785F624 Q37109353-2C8E31D6-5F40-46DE-9406-70097CE632FF Q37333665-643A8C62-2CE7-44A8-80B3-8DD917C4A55C Q37702830-3D946024-3CC8-4C08-BF07-AD85C3638855 Q38541920-A2813973-744A-4005-B1DB-1F851A67BC43 Q38868681-D8A58F19-14BF-43DF-B7F8-E9324711A37D Q39818667-0759A59C-A6D2-4597-8B74-72005F32891D Q40386857-A7FB8125-FD6B-4FC7-8569-FB2BD909614E Q40610364-84607179-D382-416B-B2A5-ABEBE3D4665C Q40867115-6DFDA4E0-F483-4A73-AD56-948F98D0CCC9 Q45041454-6E45FAE7-A1E3-4C03-98E8-F2A9A964E509 Q46815326-D010484B-6AB8-4793-AE85-3B2FB8980F6F Q46932369-B0B0B2E4-4452-44C1-8A6C-B42FF94307E9 Q47700711-8E98E748-BC31-40EF-A4E9-43540BBE00E5 Q47733513-3906D204-83D9-40EB-B44F-90257DDC0C1F Q54299588-7AC8ED1D-26E8-4F2D-8A25-F8C4F599B548 Q54502081-A441CDEA-5CD7-497E-BA2E-60CAB6F03116 Q54798312-325DDD41-6D02-41EB-92AD-9E334F796030 Q54982126-35571C74-990A-4E9C-9FEC-F15AEE7D1D75

P2860

Class III receptor tyrosine kinases: role in leukaemogenesis.

http://www.wikidata.org/entity/Q34557003

description

2002 nî lūn-bûn

@nan

2002 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մարտին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Class III receptor tyrosine kinases: role in leukaemogenesis.

@ast

Class III receptor tyrosine kinases: role in leukaemogenesis.

@en

Class III receptor tyrosine kinases: role in leukaemogenesis.

@nl

type

label

Class III receptor tyrosine kinases: role in leukaemogenesis.

@ast

Class III receptor tyrosine kinases: role in leukaemogenesis.

@en

Class III receptor tyrosine kinases: role in leukaemogenesis.

@nl

prefLabel

Class III receptor tyrosine kinases: role in leukaemogenesis.

@ast

Class III receptor tyrosine kinases: role in leukaemogenesis.

@en

Class III receptor tyrosine kinases: role in leukaemogenesis.

@nl

P1433

Q34557003-DE6FBD91-CA7B-4380-9BB2-59B76AEE7D90

P1476

Q34557003-672F1647-3BCC-43DA-9696-105BBDE46A97

P2093

Q34557003-B887E91D-AB11-44FA-9E75-ACB7BBF74314

P2860

Q34557003-0275EF4D-DD9A-432D-A166-7E466B663D72

Q34557003-04979F6F-364F-48A0-B979-5D3225A7FD57

Q34557003-0DE579E7-1296-4C61-9856-68AFEC902F1B

Q34557003-18177FE9-2AC4-4BD5-BC84-29FB2278A670

Q34557003-21989EB4-BE48-4A3B-BA70-69316963C944

Q34557003-225F9F7B-AD19-4520-A595-6695714BC677

Q34557003-231E46F4-A5A1-4F4A-A9B6-8649D0E11F73

Q34557003-295144A5-2FCF-4514-8ADA-C9EB63122A80

Q34557003-2A006836-49F7-4296-B987-4653FC0E7AF0

Q34557003-2DB15903-D29A-4B6A-9A1C-34F612D974B5

P304

Q34557003-03EC590A-942B-463A-B58A-D83876B38095

P31

Q34557003-6962A7D7-9D67-4A8B-A85A-6C426F1C8320

P356

Q34557003-54BFE718-AF77-4B04-93FD-83F19040B4C5

P407

Q34557003-08CD8665-2EE2-438E-9DF1-A2948D3DB698

P433

Q34557003-C25ECF55-A530-4ECC-98F7-2C34EA0F09A2

P478

Q34557003-707CF63D-8643-4CA6-8326-F92C290E0A3C

P577

Q34557003-5B34F4C3-0B60-4424-9054-5C61DB9F93C1

P5875

Q34557003-985EF500-9E46-4E13-AF37-8C35EFB27B9E

P698

Q34557003-7C3C3AD9-6C9D-43B9-A925-240E7C4A4CDF

P356

J.0007-1048.2001.03294.X

P1433

British Journal of Haematology

P1476

Class III receptor tyrosine kinases: role in leukaemogenesis.

@en

P2093

John T Reilly

http://www.w3.org/2001/XMLSchema#string

P2860

Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis

Basis of hematopoietic defects in platelet-derived growth factor (PDGF)-B and PDGF beta-receptor null mice

Independent expression of human alpha or beta platelet-derived growth factor receptor cDNAs in a naive hematopoietic cell leads to functional coupling with mitogenic and chemotactic signaling pathways

HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain

Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus

FMS mutations in myelodysplastic, leukemic, and normal subjects

cDNA cloning and expression of the human A-type platelet-derived growth factor (PDGF) receptor establishes structural similarity to the B-type PDGF receptor

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies.

Signal transduction by receptors with tyrosine kinase activity

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

P304

744-757

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.0007-1048.2001.03294.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2002-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11477551

http://www.w3.org/2001/XMLSchema#string

P698

11886377

http://www.w3.org/2001/XMLSchema#string